Skip to main content
. Author manuscript; available in PMC: 2022 Dec 7.
Published in final edited form as: Circulation. 2015 Aug 5;132(8):691–718. doi: 10.1161/CIR.0000000000000230

Table 6.

Drugs Approved by the FDA for Weight Loss*

Generic Name, Year of Approval Trade Name(s) Dose DEA Schedule
Pancreatic lipase inhibitor approved by the FDA for long-term use (≥12 mo)
 Orlistat,1999 Xenical 120 mg 3 times daily before meals Not scheduled
 Orlistat, 2007 Alli (over the counter) 60 mg 3 times daily before meals Not scheduled
Serotinin-2C receptor agonist approved by the FDA for long-term use (12 mo)
 Lorcaserin, 2012 Belviq 10 mg twice daily IV
Combination of phentermine-topiramate approved by the FDA for long-term use (12 mo)
 Phentermine-topiramate, 2012 Qsymia 3.75/23 mg
7.5/46 mg
15/92 mg
IV
Noradrenergic drugs approved for short-term use (usually <12 wk)
 Diethylpropion, 1959 Tenuate
Tenuate Dospan
25 mg 3 times a day
75 mg every morning
IV
 Phentermine, 1959 Adipex and many others 15–30 mg/d IV
 Benzphetamine, 1960 Didrex 25–50 mg 3 times daily III
 Phendimetrazine, 1959 Bontril
Prelu-2
17.5–70 mg 3 times daily
105 mg daily
III

DEA indicates US Drug Enforcement Administration; and FDA, US Food and Drug Administration.

*

Side effect profiles can be found in the package inserts for each agent.